Decreased expression of IRF6 is also found in highly metastatic nasopharyngeal carcinoma cells, while its overexpression proves to inhibit tumor cell proliferation and growth and enhances their chemotherapeutic sensitivity [8]. Here, IRF6 is linked to neoplasm.